📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: OmniaBio

1.1 - Company Overview

OmniaBio Logo

OmniaBio

Headquarter: Canada
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of contract development and manufacturing services for gene-modified cell therapies and viral vectors, supporting cell and gene therapy companies from preclinical through commercial scale. Capabilities include automated, closed CAR T and NK process development and manufacturing, lentiviral vector upstream/downstream process optimization, GMP iPSC reprogramming, gene editing and differentiation, cell therapy scale-up, and GMP manufacturing.

Products and services

  • Cell and Gene Therapy GMP Manufacturing: Delivers GMP-compliant manufacturing of therapeutic cell and gene therapy products at commercial scale, supporting Canadian and international companies amid demand outstripping supply
  • Immunotherapy: Architects automated, closed, integrated process development and manufacturing for CAR T and NK cells, tackling bottlenecks in immune cell proliferation and function for robust performance
  • Lentiviral Vector Manufacturing: Specializes in developing and optimizing upstream and downstream processes for lentiviral vector production, ensuring scalable and reproducible manufacturing for consistent gene-modification components

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to OmniaBio

Peptido Logo

Peptido

HQ: Germany Website
  • Description: Provider of GMP-compliant synthesis of pharmaceutical active ingredients, delivering services from lab-scale and pilot quantities to industrial-scale production for the pharmaceutical industry.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Peptido company profile →
Clinical Trial Data Logo

Clinical Trial Data

HQ: United States Website
  • Description: Provider of data management, biostatistical, and medical writing services for pharmaceutical companies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Clinical Trial Data company profile →
Citoxlab Logo

Citoxlab

HQ: France Website
  • Description: Provider of a comprehensive range of preclinical services and specialty safety evaluation services for pharmaceutical, biotechnology, and chemical companies worldwide.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Citoxlab company profile →
Phaxiam Therapeutics Logo

Phaxiam Therapeutics

HQ: France Website
  • Description: Provider of bacteriophage-based therapies to combat antimicrobial-resistant bacterial infections, offering phage treatments, GMP individualized phage therapies (IPT), standardized phage therapies medicinal products (PTMP), a phage portfolio targeting Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa, an in vitro Phagogram test for phage susceptibility, and PhagoDAIR clinical trial.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Phaxiam Therapeutics company profile →
Veranova Logo

Veranova

HQ: United States Website
  • Description: Provider of research, development, and manufacturing of sophisticated, complex active pharmaceutical ingredients (APIs) for pharmaceutical and biotech industries, applying scientific expertise and diversified talent to create fresh approaches to resolving business issues and enhancing stakeholder value.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Veranova company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for OmniaBio

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to OmniaBio

2.2 - Growth funds investing in similar companies to OmniaBio

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for OmniaBio

4.2 - Public trading comparable groups for OmniaBio

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to OmniaBio

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About OmniaBio

What does OmniaBio do?

OmniaBio is a provider of contract development and manufacturing services for gene-modified cell therapies and viral vectors, supporting cell and gene therapy companies from preclinical through commercial scale. Capabilities include automated, closed CAR T and NK process development and manufacturing, lentiviral vector upstream/downstream process optimization, GMP iPSC reprogramming, gene editing and differentiation, cell therapy scale-up, and GMP manufacturing.

Who are OmniaBio's competitors?

OmniaBio's competitors and similar companies include Peptido, Clinical Trial Data, Citoxlab, Phaxiam Therapeutics, and Veranova.

Where is OmniaBio headquartered?

OmniaBio is headquartered in Canada.

How many employees does OmniaBio have?

OmniaBio has 1,000 employees 🔒.

When was OmniaBio founded?

OmniaBio was founded in 2010 🔒.

What sector and industry vertical is OmniaBio in?

OmniaBio is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for OmniaBio

Who are the top strategic acquirers in OmniaBio's sector and industry

Top strategic M&A buyers and acquirers in OmniaBio's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for OmniaBio?

Top strategic M&A buyers groups and sectors for OmniaBio include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in OmniaBio's sector and industry vertical

Which are the top PE firms investing in OmniaBio's sector and industry vertical?

Top PE firms investing in OmniaBio's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in OmniaBio's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in OmniaBio's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in OmniaBio's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to OmniaBio include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in OmniaBio's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for OmniaBio?

The key public trading comparables and valuation benchmarks for OmniaBio include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for OmniaBio for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for OmniaBio with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in OmniaBio's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for OmniaBio with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in OmniaBio's' sector and industry vertical?

Access recent funding rounds and capital raises in OmniaBio's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for OmniaBio